NeoMab Biotechnology
- Biotech or pharma, therapeutic R&D
- CMO, CRO
NeoMab Bio has three core business:
1.Molecular License
We have over 40 ongoing projects in the pipeline, spanning various therapeutic areas such as oncology, immunology, neuroscience, and metabolism, as well as innovative platforms like TCE, NKCE and BBB. All of the projects are currently open for licensing-out partnerships.
2. Access of Fully Human Antibody Transgenic Mice
We can offer three models, including standard IgG, CLC, and HC. The NeoMab-IgG Ease version can be delivered directly to customers without any milestone payments.
3. One-Stop CRO Service for Antibody Discovery
Contact us:
Minerva Jiang, +86 18301848156, jiangm@neomab-bio.com
Linkedin: https://www.linkedin.com/in/minerva-jiang-51b338a9/
Wechat:18301848156
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}